Can This Silicon Valley Startup Bioengineer A Less Addictive Opioid?

Back in 2015, a 40-year-old synthetic biologist named Christina Smolke, along with a small team of researchers at Stanford, made a huge discovery. They proved that a genetically engineered yeast could produce opioid molecules, the core ingredients of some of the world’s most widely prescribed pain medicines.


Read the article at Fast Company

0 comments